See also this year's filing and all EDGAR filings for this company.
PDF Report 0001639225_2020_Livongo_Health_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001639225, Livongo Health Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 487,507,000 |
| 1 | AssetsNonCurrent | 3,460,000 |
| 2 | PropertyPlantAndEquipment | 0 |
| 3 | IntangibleAssets | 0 |
| 4 | LeaseAssets | 0 |
| 5 | remainder_Assets | 69,594,000 |
| 6 | LiabilitiesCurrent | 41,875,000 |
| 7 | LiabilitiesNonCurrent | 2,914,000 |
| 8 | LeaseLiability | 0 |
| 9 | remainder_Liabilities | 8,408,000 |
| 10 | CostOfGoodsAndServicesSold | 46,158,000 |
| 11 | GeneralAndAdministrativeExpense | 55,676,000 |
| 12 | SellingExpense | 78,060,000 |
| 13 | ResearchAndDevelopmentExpense | 49,842,000 |
| 14 | remainder_Expenses | -526,000 |
| 15 | remainder_Revenues | 170,198,000 |
| 16 | remainder_NetIncome | 3,742,000 |
| 17 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 560,561,000 |
| 1 | Liabilities | 53,197,000 |
| 2 | Expenses | 229,210,000 |
| 3 | Revenues | 170,198,000 |
| 4 | StockholdersEquity | 507,364,000 |
| 5 | NetIncome | -55,270,000 |
| 6 | ComprehensiveNetIncome | -55,270,000 |
| 7 | BaseVar | 516,517,000 |
| 8 | EconomicCapitalRatio | 3.75 |
Edgar->Model Mapping
Feature Distribution
